BACKGROUND: Sputum eosinophil percentages are a strong predictor of airway inflammation and exacerbations and aid asthma management, whereas sputum neutrophil percentages indicate a different severe asthma phenotype that is potentially less responsive to TH2-targeted therapy. Variables, such as blood eosinophil counts, total IgE levels, fraction of exhaled nitric oxide (Feno) levels, or FEV1 percent predicted, might predict airway eosinophil percentages, whereas age, FEV1 percent predicted, or blood neutrophil counts might predict sputum neutrophil percentages. Availability and ease of measurement are useful characteristics, but accuracy in predicting airway eosinophil and neutrophil percentages either individually or combined is not established. OBJECTIVES: We sought to determine whether blood eosinophil counts, Feno levels, and IgE levels accurately predict sputum eosinophil percentages and whether age, FEV1 percent predicted, and blood neutrophil counts accurately predict sputum neutrophil percentages. METHODS: Subjects in the Wake Forest Severe Asthma Research Program (n = 328) were characterized by blood and sputum cell counts, health care use, lung function, Feno levels, and IgE levels. Multiple analytic techniques were used. RESULTS: Despite significant association with sputum eosinophil percentages, blood eosinophil counts, Feno levels, and total IgE levels did not accurately predict sputum eosinophil percentages, and combinations of these variables did not improve prediction. Age, FEV1 percent predicted, and blood neutrophil counts were similarly unsatisfactory for the prediction of sputum neutrophil percentages. Factor analysis and stepwise selection found Feno levels, IgE levels, and FEV1 percent predicted, but not blood eosinophil counts, correctly predicted 69% of sputum eosinophil percentages of less than 2% or 2% and greater. Likewise, age, asthma duration, and blood neutrophil counts correctly predicted 64% of sputum neutrophil percentages of less than 40% or 40% and greater. A model to predict both sputum eosinophil and neutrophil percentages accurately assigned only 41% of samples. CONCLUSION: Despite statistically significant associations, Feno levels, IgE levels, blood eosinophil and neutrophil counts, FEV1 percent predicted, and age are poor surrogates, both separately and combined, for accurately predicting sputum eosinophil and neutrophil percentages.
BACKGROUND: Sputum eosinophil percentages are a strong predictor of airway inflammation and exacerbations and aid asthma management, whereas sputum neutrophil percentages indicate a different severe asthma phenotype that is potentially less responsive to TH2-targeted therapy. Variables, such as blood eosinophil counts, total IgE levels, fraction of exhaled nitric oxide (Feno) levels, or FEV1 percent predicted, might predict airway eosinophil percentages, whereas age, FEV1 percent predicted, or blood neutrophil counts might predict sputum neutrophil percentages. Availability and ease of measurement are useful characteristics, but accuracy in predicting airway eosinophil and neutrophil percentages either individually or combined is not established. OBJECTIVES: We sought to determine whether blood eosinophil counts, Feno levels, and IgE levels accurately predict sputum eosinophil percentages and whether age, FEV1 percent predicted, and blood neutrophil counts accurately predict sputum neutrophil percentages. METHODS: Subjects in the Wake Forest Severe Asthma Research Program (n = 328) were characterized by blood and sputum cell counts, health care use, lung function, Feno levels, and IgE levels. Multiple analytic techniques were used. RESULTS: Despite significant association with sputum eosinophil percentages, blood eosinophil counts, Feno levels, and total IgE levels did not accurately predict sputum eosinophil percentages, and combinations of these variables did not improve prediction. Age, FEV1 percent predicted, and blood neutrophil counts were similarly unsatisfactory for the prediction of sputum neutrophil percentages. Factor analysis and stepwise selection found Feno levels, IgE levels, and FEV1 percent predicted, but not blood eosinophil counts, correctly predicted 69% of sputum eosinophil percentages of less than 2% or 2% and greater. Likewise, age, asthma duration, and blood neutrophil counts correctly predicted 64% of sputum neutrophil percentages of less than 40% or 40% and greater. A model to predict both sputum eosinophil and neutrophil percentages accurately assigned only 41% of samples. CONCLUSION: Despite statistically significant associations, Feno levels, IgE levels, blood eosinophil and neutrophil counts, FEV1 percent predicted, and age are poor surrogates, both separately and combined, for accurately predicting sputum eosinophil and neutrophil percentages.
Authors: Catherine Lemière; Pierre Ernst; Ron Olivenstein; Yasuhiro Yamauchi; Karuthapillai Govindaraju; Mara S Ludwig; James G Martin; Qutayba Hamid Journal: J Allergy Clin Immunol Date: 2006-09-25 Impact factor: 10.793
Authors: Simon P Hogan; Helene F Rosenberg; Redwan Moqbel; Simon Phipps; Paul S Foster; Paige Lacy; A Barry Kay; Marc E Rothenberg Journal: Clin Exp Allergy Date: 2008-04-01 Impact factor: 5.018
Authors: L Jayaram; M M Pizzichini; R J Cook; L-P Boulet; C Lemière; E Pizzichini; A Cartier; P Hussack; C H Goldsmith; M Laviolette; K Parameswaran; F E Hargreave Journal: Eur Respir J Date: 2006-03 Impact factor: 16.671
Authors: Dominick E Shaw; Mike A Berry; Mike Thomas; Ruth H Green; Chris E Brightling; Andrew J Wardlaw; Ian D Pavord Journal: Am J Respir Crit Care Med Date: 2007-05-11 Impact factor: 21.405
Authors: Prescott G Woodruff; Homer A Boushey; Gregory M Dolganov; Chris S Barker; Yee Hwa Yang; Samantha Donnelly; Almut Ellwanger; Sukhvinder S Sidhu; Trang P Dao-Pick; Carlos Pantoja; David J Erle; Keith R Yamamoto; John V Fahy Journal: Proc Natl Acad Sci U S A Date: 2007-09-26 Impact factor: 11.205
Authors: Parameswaran Nair; Marcia M M Pizzichini; Melanie Kjarsgaard; Mark D Inman; Ann Efthimiadis; Emilio Pizzichini; Frederick E Hargreave; Paul M O'Byrne Journal: N Engl J Med Date: 2009-03-05 Impact factor: 91.245
Authors: Jodie L Simpson; Heather Powell; Michael J Boyle; Rodney J Scott; Peter G Gibson Journal: Am J Respir Crit Care Med Date: 2007-10-18 Impact factor: 21.405
Authors: Kittipong Maneechotesuwan; Sarah Essilfie-Quaye; Sergei A Kharitonov; Ian M Adcock; Peter J Barnes Journal: Chest Date: 2007-06-05 Impact factor: 9.410
Authors: B Balbi; P Pignatti; M Corradi; P Baiardi; L Bianchi; G Brunetti; A Radaeli; G Moscato; A Mutti; A Spanevello; M Malerba Journal: Eur Respir J Date: 2007-10 Impact factor: 16.671
Authors: Eleanor M Dunican; Brett M Elicker; David S Gierada; Scott K Nagle; Mark L Schiebler; John D Newell; Wilfred W Raymond; Marrah E Lachowicz-Scroggins; Selena Di Maio; Eric A Hoffman; Mario Castro; Sean B Fain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; Serpil C Erzurum; Sally E Wenzel; Deborah A Meyers; Eugene R Bleecker; Brenda R Phillips; David T Mauger; Erin D Gordon; Prescott G Woodruff; Michael C Peters; John V Fahy Journal: J Clin Invest Date: 2018-02-05 Impact factor: 14.808
Authors: Marrah E Lachowicz-Scroggins; Eleanor M Dunican; Annabelle R Charbit; Wilfred Raymond; Mark R Looney; Michael C Peters; Erin D Gordon; Prescott G Woodruff; Emma Lefrançais; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Merritt L Fajt; Sally E Wenzel; Elliot Israel; Bruce D Levy; John V Fahy Journal: Am J Respir Crit Care Med Date: 2019-05-01 Impact factor: 21.405
Authors: Jose T Melo; Tanushree Tunstall; Marcia M M Pizzichini; Rosemeri Maurici; Cristiane C Rocha; Felipe Dal-Pizzol; Jessica Gonçalves; Trevor T Hansel; Ryan S Thwaites; Emilio Pizzichini Journal: Am J Respir Crit Care Med Date: 2019-01-15 Impact factor: 21.405